Brief: Agilon Health Q1 Revenue USD 1,600 Million Vs. IBES Estimate USD 1,604 Million
07/05/2024 21:00
May 07 (Reuters) - Agilon Health Q1 adjusted EBITDA USD 29 million vs. IBES estimate USD 16.8 million. * Q1 net income USD -6 million vs. IBES estimate USD -5.32 million
Recent news on Agilon Health
See all newsU.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology
U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise
U.S. STOCKS ON THE MOVE-Albemarle, Howmet, Travere Therapeutics